Loading clinical trials...
Loading clinical trials...
A Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population
Conditions
Interventions
OPTI-BIOME™ Bacillus subtilis MB40
Placebo
Locations
3
United States
KGK Clinical Trials Center
Foothill Ranch, California, United States
KGK Clinical Trials Center
Orlando, Florida, United States
KGK Synergize Inc.
London, Ontario, Canada
Start Date
October 1, 2016
Primary Completion Date
February 1, 2017
Completion Date
February 1, 2017
Last Updated
October 29, 2021
NCT07215351
NCT06122571
NCT02277431
NCT04182178
Lead Sponsor
BIO-CAT Microbials, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions